Align argininosuccinate lyase (EC 4.3.2.1) (characterized)
to candidate GFF334 PGA1_c03450 argininosuccinate lyase ArgH
Query= BRENDA::Q8DVX5 (460 letters) >FitnessBrowser__Phaeo:GFF334 Length = 456 Score = 416 bits (1068), Expect = e-120 Identities = 225/454 (49%), Positives = 290/454 (63%), Gaps = 1/454 (0%) Query: 8 LWGGRFEAGLAQWVEEFGASISFDQKLAEFDLKGSIAHVTMLGEKGIISQEDAATIKAGL 67 +WGGRF AG +E ASI FD+++A D+ GS AH ML G+I+ DA I+ GL Sbjct: 1 MWGGRFAAGPDAIMEAINASIGFDKRMAAQDIAGSRAHAAMLAATGVITDNDAEAIREGL 60 Query: 68 EDLLEEYKAGQLKFDVSNEDIHMNMESLLTAKIGPVAGKLHTARSRNDQVATDMHLYLKA 127 +L E + G +F + EDIHMN+E+ L IG AG+LHT RSRNDQVATD L+++ Sbjct: 61 LTVLSEIEGGTFQFSTALEDIHMNVEARLKDIIGEPAGRLHTGRSRNDQVATDFKLWVRD 120 Query: 128 KLDEVIEKLANLRTVLVDLADKHVHTIMPGYTHLQHAQPISFGHHLMAYYNMFTRDSERF 187 +LD L L L+ A+ +MPG+THLQ AQP+++GHH+MAY MF RD R Sbjct: 121 QLDAAESGLLALIRALLSQAEAGADWVMPGFTHLQTAQPVTWGHHMMAYVEMFGRDLSRV 180 Query: 188 IFNVKHTDLSPLGAAALAGTTFPIDREMTAQLMGFAEPYSNSLDAVSDRDFILEFLSNAS 247 K + SPLGAAALAGT+FPIDREMTA +GF P +NSLDAVSDRDF LEFLS AS Sbjct: 181 RDARKRMNESPLGAAALAGTSFPIDREMTASALGFDRPAANSLDAVSDRDFALEFLSVAS 240 Query: 248 ILMMHMSRMCEEVISWCSHEYQFVTLSDTFSTGSSIMPQKKNPDMAELIRGKSGRVYANL 307 I +H+SR EE++ W S +++FVTLSD FSTGSSIMPQKKNPD AELIR K GR++ Sbjct: 241 ISAVHLSRFAEELVIWSSAQFRFVTLSDRFSTGSSIMPQKKNPDAAELIRAKVGRIFGAN 300 Query: 308 FGLLTVMKALPLAYNKDLQEDKEGMFDTAETITVALDILAGMLSSMIVNDKHMAESTQKD 367 L+ VMK LPLAY+KD+QEDKE +FD A+ +AL + GM+ M N +A + Sbjct: 301 TALMMVMKGLPLAYSKDMQEDKEQVFDAADNWMLALAAMEGMVKDMTGNRAELAAAAGSG 360 Query: 368 FSNATELADYLAS-KGMPFRQAHEIVGKLILECSKNGHYLQDVPLERYQTISDLIEEDVY 426 FS AT+LAD++ +PFR AH + G L+ G L D+ L Q + + I ED++ Sbjct: 361 FSTATDLADWMVRVLKVPFRDAHHVTGTLVAMAESRGCDLPDLTLADMQGVHEGITEDIF 420 Query: 427 ETLKSHTAVERRHSLGGTGFEQVKWQIAEAKKAL 460 L +V R S GGT QV+ QIA + L Sbjct: 421 SVLGVENSVNSRMSYGGTAPAQVRAQIARWQDVL 454 Lambda K H 0.318 0.132 0.378 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 564 Number of extensions: 22 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 460 Length of database: 456 Length adjustment: 33 Effective length of query: 427 Effective length of database: 423 Effective search space: 180621 Effective search space used: 180621 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 51 (24.3 bits)
Align candidate GFF334 PGA1_c03450 (argininosuccinate lyase ArgH)
to HMM TIGR00838 (argH: argininosuccinate lyase (EC 4.3.2.1))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR00838.hmm # target sequence database: /tmp/gapView.3038.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR00838 [M=455] Accession: TIGR00838 Description: argH: argininosuccinate lyase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 9.2e-185 600.9 0.0 1e-184 600.7 0.0 1.0 1 lcl|FitnessBrowser__Phaeo:GFF334 PGA1_c03450 argininosuccinate ly Domain annotation for each sequence (and alignments): >> lcl|FitnessBrowser__Phaeo:GFF334 PGA1_c03450 argininosuccinate lyase ArgH # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 600.7 0.0 1e-184 1e-184 1 452 [. 1 452 [. 1 455 [. 0.99 Alignments for each domain: == domain 1 score: 600.7 bits; conditional E-value: 1e-184 TIGR00838 1 lwggRlkkeldkavaefnaslsfDkelaeaDiegsiahtkaLakagilteeeakklieaLeelkeevkegklelevd 77 +wggR++ ++d +++ nas+ fDk++a++Di gs ah+++La +g++t+++a+ ++e+L ++ +e++ g++++++ lcl|FitnessBrowser__Phaeo:GFF334 1 MWGGRFAAGPDAIMEAINASIGFDKRMAAQDIAGSRAHAAMLAATGVITDNDAEAIREGLLTVLSEIEGGTFQFSTA 77 6**************************************************************************** PP TIGR00838 78 aeDiHlavErelidkvgedvgkklhtgrsRnDqvatdlrlylrdkvkelaealkdllkalvekAekevetlmpgytH 154 eDiH++vE++l d +ge +g +lhtgrsRnDqvatd++l++rd+++ + l++l++al+ +Ae+ + +mpg+tH lcl|FitnessBrowser__Phaeo:GFF334 78 LEDIHMNVEARLKDIIGEPAG-RLHTGRSRNDQVATDFKLWVRDQLDAAESGLLALIRALLSQAEAGADWVMPGFTH 153 *****************7766.******************************************************* PP TIGR00838 155 LqrAqPitlaHhllayaemlerDleRlldalkRvnksPlGsgAlagtsfeidrellaelLgFdavvensldavsdRD 231 Lq AqP+t++Hh++ay+em+ rDl+R+ da kR+n+sPlG++Alagtsf+idre++a+ LgFd+ ++nsldavsdRD lcl|FitnessBrowser__Phaeo:GFF334 154 LQTAQPVTWGHHMMAYVEMFGRDLSRVRDARKRMNESPLGAAALAGTSFPIDREMTASALGFDRPAANSLDAVSDRD 230 ***************************************************************************** PP TIGR00838 232 fiiEllsaaallmvhlsrlaEelilfsseEfgfvelsdevssgssimPqKKnpDvaEliRgktgrviGnltglltil 308 f++E+ls+a++ +vhlsr+aEel+++ss+ f fv+lsd++s+gssimPqKKnpD+aEliR+k gr++G t+l++++ lcl|FitnessBrowser__Phaeo:GFF334 231 FALEFLSVASISAVHLSRFAEELVIWSSAQFRFVTLSDRFSTGSSIMPQKKNPDAAELIRAKVGRIFGANTALMMVM 307 ***************************************************************************** PP TIGR00838 309 KalPlaYnkDlqEdkealfdalktveellevvtgllkelkvnkerleeaakknfalatdlAdylvrk.GvPFReahe 384 K+lPlaY kD+qEdke++fda +++ +l +++g++k+++ n+ +l+ aa ++f++atdlAd++vr vPFR+ah+ lcl|FitnessBrowser__Phaeo:GFF334 308 KGLPLAYSKDMQEDKEQVFDAADNWMLALAAMEGMVKDMTGNRAELAAAAGSGFSTATDLADWMVRVlKVPFRDAHH 384 ******************************************************************99********* PP TIGR00838 385 ivGevvakaiekGkkleeltleelqklsekleedvlevldleeavekrdakGGtakeevekaieeaka 452 ++G +va a+ +G +l +ltl+ +q ++e ++ed+++vl +e++v+ r+++GGta+++v+ +i+ + lcl|FitnessBrowser__Phaeo:GFF334 385 VTGTLVAMAESRGCDLPDLTLADMQGVHEGITEDIFSVLGVENSVNSRMSYGGTAPAQVRAQIARWQD 452 ***************************************************************98765 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (455 nodes) Target sequences: 1 (456 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.02u 0.01s 00:00:00.03 Elapsed: 00:00:00.02 # Mc/sec: 8.18 // [ok]
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Apr 09 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory